You are here: Home » 2025 » October » Archives for 27th

Appian e IFC firmam parceria para lançar novo fundo de US$ 1 bilhão em minerais e metais fundamentais para mercados emergentes

ABU DHABI, Emirados Árabes Unidos, Oct. 27, 2025 (GLOBE NEWSWIRE) — A Appian Capital Advisory Limited (“Appian”), consultora de investimentos de fundos de capital privado voltados para valor de longo prazo que investem em empresas de metais, mineração e setores adjacentes, anuncia o lançamento de um fundo de minerais fundamentais, metais e mineração para mercados emergentes (o “Fundo”) em parceria com a International Finance Corporation (“IFC”), membro do World Bank Group. O Fundo terá um compromisso total de capital de até US$ 1 bilhão e investirá ao lado dos fundos existentes e futuros da Appian, apoiando o desenvolvimento de projetos de mineração responsáveis e de alto impacto para commodities essenciais ao acesso à energia, setores fundamentais e tecnologias voltadas para o futuro.

Destaques

  • A IFC será a investidora principal do Fundo, com uma contribuição inicial de US$ 100 milhões. O capital adicional será mobilizado pela IFC Asset Management Company (AMC).
  • O Fundo investirá em ações, crédito e royalties, com a missão de gerar retornos financeiros robustos enquanto contribui para o impacto no desenvolvimento, a criação de empregos e melhores resultados para a comunidade.
  • É o primeiro fundo de mineração dedicado exclusivamente a mercados emergentes, concentrando–se nos minerais fundamentais e commodities necessários para o crescimento econômico, a transição energética e tecnologias digitais importantes.
  • Trata–se do primeiro fundo da IFC estabelecido em parceria com um investidor de private equity em metais e mineração.
  • Todos os investimentos estarão sujeitos aos padrões de ESG e desempenho da IFC, que atendem ou excedem as melhores práticas internacionais em mineração responsável.
  • O primeiro investimento do Fundo é no projeto em operação Santa Rita, da Atlantic Nickel, no Brasil. Este é um coinvestimento junto à Appian para promover o desenvolvimento subterrâneo de um ativo de grande escala de níquel–cobre–cobalto com vida útil de mina superior a 30 anos.
  • As equipes de gestão apoiadas pelo Fundo terão acesso à profunda expertise técnica e financeira da Appian para acelerar o desenvolvimento do projeto e a criação de valor, juntamente com suporte de ESG, desenvolvimento comunitário e engajamento de stakeholders pelos especialistas em sustentabilidade da IFC e do World Bank.
  • A IFC e a Appian possuem uma relação de investimento de dez anos, incluindo dois investimentos em terras raras e ouro, na África, que resultaram em construções de minas bem–sucedidas e realizações.

O Fundo tem a IFC como principal investidora e se alinha com a missão de investimento da instituição para financiar o desenvolvimento do setor privado em mercados emergentes, entregando tanto retornos financeiros quanto impacto mensurável no desenvolvimento. Além disso, o fundo terá o dever fiduciário para com os investidores introduzidos pela AMC, garantindo que seus interesses sejam protegidos por meio de supervisão disciplinada, transparência e compromisso com a criação de valor de longo prazo.

Gerido pela Appian, o Fundo coinvestirá ao lado do Appian Natural Resources Fund III e do Appian Credit Strategies Fund I (juntos, “os fundos”), assim como futuros fundos da Appian. Ele terá como alvo investimentos em ações, crédito e royalties nos setores de metais, mineração e setores adjacentes em mercados emergentes, com foco na África e na América Latina. Todos os investimentos realizados através do Fundo deverão atender aos rigorosos critérios de desempenho e aos padrões ambientais, sociais e de governança (“ESG”) da IFC.

O Fundo concordou em investir na mina de níquel–cobre–cobalto Santa Rita, localizada no estado da Bahia, Brasil, que atualmente está em transição para produção subterrânea. Espera–se que a mina aumente a produção para aproximadamente 30.000 toneladas por ano em equivalente de níquel, com uma vida útil superior a 30 anos. A mina é propriedade da Atlantic Nickel, uma afiliada integral da Appian. A IFC está investindo nas mesmas condições que os demais investidores, com os termos acordados após avaliações independentes do ativo realizadas pelo Citi e pelo Standard Chartered.

O Fundo é o primeiro veículo com foco em mineração estabelecido exclusivamente para investir em mercados emergentes. Ele financiará projetos de desenvolvimento mineral em todas as etapas, incluindo construção, produção e expansão, promovendo crescimento econômico duradouro e benefícios sociais nos países anfitriões por meio de capacitação, criação de empregos, exportações e contribuições para receitas fiscais. Minerais e metais fundamentais são a base da economia global moderna. À medida que o mundo acelera sua transição para a inovação digital e energia verde, esses recursos são fundamentais para um crescimento global mais igualitário, inclusivo e sustentável.

A parceria entre a IFC e a Appian representa a primeira colaboração da IFC com um investidor de private equity especializado em mineração para desenvolver um fundo dedicado. A Appian possui aproximadamente US$ 5 bilhões1 em ativos sob gestão, apoiada por uma equipe de mais de 100 profissionais experientes em investimentos, combinando expertise financeira e técnica para identificar e otimizar projetos de metais e mineração, criando valor de longo prazo para seus investidores. Desde 2016, a Appian colocou 12 projetos de mineração em produção, um número que supera as cinco maiores empresas de mineração internacionais juntas no mesmo período.

Michael W. Scherb, fundador e CEO da Appian, comentou: “Estamos orgulhosos de que a IFC tenha confiado à Appian a gestão deste fundo histórico. Este é um forte endosso à nossa capacidade de identificar e desenvolver de forma responsável ativos de alta qualidade, desbloqueando valor de longo prazo para nossos parceiros. Isso também ressalta o papel vital que a mineração pode desempenhar no impulsionamento do crescimento econômico sustentável e na geração de benefícios duradouros para as comunidades locais, particularmente em regiões onde as necessidades de desenvolvimento são mais urgentes. As equipes de gestão apoiadas pelo Fundo agora contarão com o suporte de duas instituições líderes em nosso setor. Esperamos avançar nesta parceria para acelerar o desenvolvimento responsável e sustentável de recursos em nível global.”

Makhtar Diop, Diretor–Geral da IFC, comentou: “A IFC está encantada com a oportunidade de se associar novamente à Appian neste veículo de investimento inovador. Minerais são essenciais para a construção de setores, criação de empregos e estímulo ao crescimento econômico. Parcerias com empresas como a Appian ajudarão a trazer mais capital privado para os lugares que mais precisam, ampliando o acesso a recursos fundamentais e permitindo que as comunidades locais se beneficiem do desenvolvimento de sua riqueza mineral.”

Para mais informações

Appian Capital Advisory Limited
Andrew Todd, Diretor de Comunicações: +44 7990416759/[email protected]
+44 (0)20 7004 0951/[email protected]

Sobre a Appian Capital Advisory Limited

A Appian Capital Advisory Limited é a consultora de investimentos de fundos de capital privado voltados para o valor de longo prazo, que investem em empresas nos setores de metais, mineração e setores adjacentes.

A Appian é uma consultora de investimentos de destaque, com experiência global na América do Sul, América do Norte, Austrália e África, e histórico de sucesso no apoio a empresas nos setores de metais, mineração e setores adjacentes para atingir suas metas de desenvolvimento, com um portfólio operacional global supervisionando aproximadamente 6.000 funcionários.

A Appian conta com uma equipe global de mais de 100 profissionais experientes em investimentos, combinando expertise financeira e técnica, com presença em Abu Dhabi, Belo Horizonte, Dubai, Hong Kong, Lima, Londres, Nova York, Perth, São Paulo e Toronto. Para mais informações, acesse www.appiancapitaladvisory.com ou nos encontre no LinkedIn, Instagram ou Twitter/X.

Sobre a IFC
A IFC – membro do World Bank Group – é a maior instituição global de desenvolvimento voltada para o setor privado em mercados emergentes. Atuamos em mais de 100 países, usando nosso capital, expertise e influência para criar mercados e oportunidades em países em desenvolvimento. No ano fiscal de 2025, a IFC destinou um recorde de US$ 71,7 bilhões a empresas privadas e instituições financeiras em países em desenvolvimento, alavancando soluções do setor privado e mobilizando capital privado para criar um mundo livre da pobreza em um planeta habitável. Para mais informações, acesse www.ifc.org.

Sobre a Atlantic Nickel
A mina de níquel Santa Rita (“Atlantic Nickel” desde o 2º trimestre de 2019, anteriormente conhecida como Mirabela Mineração do Brasil) é uma mina de níquel sulfetado (“NiS”) a céu aberto em operação, localizada no estado da Bahia, no nordeste do Brasil. A Appian adquiriu a mina em 2018, otimizou o projeto da cava, reformou as instalações de processamento e reiniciou as operações com sucesso em 2019. As operações atuais envolvem mineração a céu aberto e um concentrador com capacidade de aproximadamente 6,5 milhões de toneladas por ano, produzindo um concentrado de sulfeto de níquel. O concentrado também contém subprodutos, como cobre, cobalto, platina, paládio e ouro. Em 2024, a Santa Rita processou 6,6 milhões de toneladas (Mt) de minério a céu aberto, produzindo 31,8 milhões de libras de níquel, 10,1 milhões de libras de cobre e 0,6 milhão de libras de cobalto em concentrados.

A Appian está avançando no desenvolvimento de um grande recurso subterrâneo de maior teor, estendendo a vida útil inicial da mina a céu aberto de 8 anos para mais de 30 anos. Em 2024, a Atlantic Nickel entregou seu Estudo de Pré–Viabilidade (“PFS”) para a expansão subterrânea da mina. O PFS reforçou ainda mais a confiança da Appian no projeto, delineando uma mina de longa duração com maior produção anual, baixa intensidade de capital e estrutura de custos competitiva. A Atlantic Nickel está avançando nesse cenário por meio do Estudo de Viabilidade Definitiva em andamento, com os trabalhos iniciais já iniciados para o desenvolvimento subterrâneo.

1 Em 10 de outubro de 2025. Estima–se o montante aproximado de US$ 1,0 bilhão em compromissos totais para o Appian EM Fund LP e um fechamento máximo de US$ 400 milhões para o Appian Credit Strategies I.

Uma foto que acompanha este anúncio está disponível em http://www.globenewswire.com/NewsRoom/AttachmentNg/784116a7–4e43–42b7–9677–f676293d0e94


GLOBENEWSWIRE (Distribution ID 1001135310)

اليانصيب يعلن عن أول فائز بالجائزة الكبرى بقيمة 100 مليون درهم

أبوظبي، الإمارات العربية المتحدة, Oct. 27, 2025 (GLOBE NEWSWIRE) —

اعلن اليانصيب، الذي يديره شركة ذا جيم المحدودة اليوم عن أول فائز بالجائزة الكبرى البالغة 100,000,000  درهم إماراتي، في إنجاز غير مسبوق يُعد محطة بارزة في قطاع الترفيه والألعاب التجارية في دولة الإمارات. وقد فاز الرابح أنيل كومار بولا، من الهند والبالغ من العمر 29 عاماً، بالجائزة الكبرى في سحب يوم الحظ الثالث والعشرين رقم #251018 الذي أُقيم يوم السبت، 18 أكتوبر 2025، ليصبح مليونيراً ويخلّد اسمه في تاريخ اليانصيب.

كان أنيل كومار، الذي يقيم منذ فترة طويلة في إمارة أبوظبي، في منزله عندما تلقى المكالمة من فريق اليانصيب، والتي غيّرت مجرى حياته.  وكان أنيل من أحد المشاركين الدائمين في السحوبات منذ انطلاق اليانصيب، ولم يتمكن من تصديق الخبر في البداية، معبّراً عن دهشته وسعادته الغامرة، وقال إنه ما زال غير قادر على استيعاب ما حدث. وقد شارك الخبر أولاً مع أحد زملائه قبل أن يتصل بشقيقه في الهند.

وقال بولا بتأثر: “هذا الفوز يفوق كل أحلامي. عندما تلقيت الاتصال من فريق اليانصيب، لم أصدق الأمر وطلبت منهم تكرار الخبر  أكثر من مرة. استغرق الأمر بعض الوقت لكي استوعب ما حدث، وحتى اليوم ما زلت غير مصدق لواقعي الجديد.”

وأضاف: “سيغيّر هذا المبلغ حياتي إلى الأبد. أول ما سأفعله هو أنني سأشتري سيارة فارهة، ثم سأقضي شهر كامل في فندق من فئة السبع نجوم، وبعدها سأخطط بعناية لكيفية استثمار هذا المبلغ بحكمة. فوزي هذا هو دليل على أن الأمل والحظ قد يجتمعان في لحظة غير متوقعة ليغيّرا حياة الإنسان.”

تأثير الأم في حظه

اختار بولا أرقامه المميزة بمزيج من الصدفة والمعنى الشخصي، فقد جمع بين رقم تم اختياره عشوائياً من مجموعة “الأيام” والرقم 11  من مجموعة “الأشهر”، تكريماً لشهر ميلاد والدته، دون أن يدرك أنه بهذا القرار سيصبح أول فائز بجائزة الـ 100 مليون درهم في تاريخ اليانصيب.

ويُضفي توقيت الفوز رمزية استثنائية، إذ تزامن مع الديوالي، وهو احتفال الأنوار الهندي الذي يجسّد معاني الأمل والبدايات الجديدة والازدهار. وقال بولا:”أشعر أن في هذا الفوز بركة مميزة، والفوز في مناسبة بهذه الرمزية يجعل اللحظة أكثر معنى.”

أمسية استثنائية حافلة بالأرقام القياسية

لم يكن بولا الفائز الوحيد في تلك الليلة؛ فقد شهد سحب يوم الحظ رقم #251018 فوز عشرة مشاركين آخرين بجوائز بلغت 100,000 درهم لكل منهم، مما زاد من حماس الأمسية التي اعتُبرت من أكبر السحوبات في تاريخ اللعبة.

ومنذ انطلاقه، قدّم اليانصيب أكثر من  200 جائزة بقيمة 100,000 درهم، وفاز أكثر من  100,000 لاعب بجوائز تجاوز مجموعها 147 مليون درهم. ويُعد هذا السحب محطة بارزة في تطوّر قطاع الألعاب التجارية واليانصيب في دولة الإمارات، فضلاً عن كونه إنجازاً شخصياً استثنائياً للفائز بولا.

وفي هذا الإطار، قال سكوت بيرتون، مدير الألعاب التجارية في اليانصيب “نهنئ أنيل كومار على هذا الفوز الاستثنائي. فالحصول على جائزة بقيمة 100 مليون درهم لا يغيّر حياة الفائز فحسب، بل يشكّل أيضاً إنجازاً مهماً في مسيرة اليانصيب، ويجسّد التزامنا بإسعاد الناس من خلال توفير تجارب ألعاب منظمة وممتعة ومسؤولة. إن الإقبال المتزايد من المشاركين يعكس الثقة الحقيقية التي يوليها اللاعبون لليانصيب.”

أكثر من مجرد لعبة

يخضع اليانصيب لإشراف الهيئة العامة لتنظيم الألعاب التجارية (GCGRA)، وقد رسخ مكانته كمنصة موثوقة تمتاز بالفائزين الحقيقيين والجوائز المضمونة والالتزام بمبادئ اللعب المسؤول. ومع كل سحب جديد، يواصل تقديم لحظات مليئة بالفرح والمصداقية، ترتكز على والنزاهة وحماية اللاعبين.

ومع ختام هذا الفوز التاريخي، تتجه الأنظار الآن إلى السحب المباشر القادم Lucky Day الذي سيُقام يوم السبت، 1 نوفمبر 2025، في تمام الساعة 8:30 مساءً، مع فرص جديدة للفوز بملايين الدراهم. فمن سيكون الفائز التالي؟

للمزيد من المعلومات حول أسعار التذاكر والمواعيد وطريقة المشاركة، يُرجى زيارة الموقع الإلكتروني:
www.theuaelottery.ae

للمزيد من المعلومات، الرجاء الإتصال بفريق ذا جيم واليانصيب على: [email protected]

الصورة المصاحبة لهذا الإعلان متاحة على
https://www.globenewswire.com/NewsRoom/AttachmentNg/ea33018d–fbf0–40e6–8ead–965bb8ac5b07/ar


GLOBENEWSWIRE (Distribution ID 1001135299)

The UAE Lottery announces the AED 100 Million Grand Prize Winner

ABU DHABI, United Arab Emirates, Oct. 27, 2025 (GLOBE NEWSWIRE) — The UAE Lottery, operated by the Game LLC, has made history as it officially announces the first–ever Grand Prize winner of AED 100,000,000, a moment that marks an unprecedented milestone for the country’s entertainment and gaming industry. 

Anilkumar Bolla, a 29–year–old Indian national and long–time Abu Dhabi resident, struck gold in The UAE Lottery’s 23rd Lucky Day Draw #251018 held on Saturday, October 18, 2025, becoming an instant multimillionaire and forever signing his name in The UAE Lottery’s record books.

At the time of the draw, Anilkumar was at home relaxing when he received the life–changing call from The UAE Lottery. A loyal participant since the lottery’s launch, he was completely shocked and overjoyed by the news, admitting he still can’t believe it happened. Anilkumar first shared the exciting news with a colleague before calling his brother back home in India.

“This win is beyond my wildest dreams,” said emotional Bolla. Recounting the event, he confirmed that he was absolutely stunned to learn that he won the AED 100,000,000 prize. “When I received a call from The UAE Lottery, I thought it was surreal. I kept asking them to repeat the message. It took time to sink in, and even today, I still can’t believe my new reality.”

He added: “This sum will change my life forever. I plan to buy a supercar first and treat myself to a month–long stay at a seven–star hotel. I will also take time to carefully plan how to invest this money wisely. My win is proof that hope and luck can align for anyone, especially when they least expect it.”

A Mother’s Influence on The Winner’s Luck

Bolla selected his winning numbers with a blend of chance and heartfelt meaning. His winning ticket combined an Easy Pick from the ”Days set” and the number 11 from the “Months set” to honor the month of his mother’s birthday, unknowingly sealing his fate as the first–ever AED 100,000,000 winner in The UAE Lottery’s history.

What makes this win even more symbolic is its unique timing, just on the eve of Diwali, the Indian festival of lights, which symbolizes new beginnings, hope, and prosperity. “It feels like an exceptional blessing,” said Bolla. “Winning on such an auspicious occasion makes it even more meaningful.”

A Record–Breaking Evening

While Bolla made history, he wasn’t the only winner that evening. The Lucky Day Draw #251018 also celebrated 10 other lucky winners who walked away with AED 100,000 each, adding to the excitement of what was a record–breaking draw.

Since its launch, The UAE Lottery has awarded over 200 winners of AED 100,000, and more than 100,000 players have claimed prizes totaling over AED 147 million. This latest draw not only marks a personal victory for Bolla, but a defining moment for the UAE’s growing lottery and gaming scene.

“First, congratulations to Anilkumar on this phenomenal win,” said Scott Burton, Commercial Gaming Director at The UAE Lottery. “The AED 100,000,000 prize will not only change his life but also signifies a remarkable milestone for The UAE Lottery, reinforcing our mission to uplift people’s lives while delivering regulated, exciting, and fun lottery experiences. Our growing participant base reflects the genuine interest and trust that players place in The UAE Lottery.” Scott concluded.

More Than Just a Game

Regulated by the GCGRA, The UAE Lottery has quickly become a trusted platform known for real winners, guaranteed prizes, and responsible play. With every draw, it continues to deliver meaningful moments, grounded in fairness, integrity, and player protection.

As the excitement settles from this historic win, all eyes now turn to the next live Lucky Day Draw, taking place on Saturday, November 1, 2025, at 8:30 PM. With millions more up for grabs, who will be next?

Visit www.theuaelottery.ae for ticket pricing, upcoming draws, and how to play.

For media enquiries, please contact:
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ea33018d–fbf0–40e6–8ead–965bb8ac5b07/en


GLOBENEWSWIRE (Distribution ID 1001135299)

CGTN：Dialogue, development and shared prosperity

BEIJING, Oct. 27, 2025 (GLOBE NEWSWIRE) — As geopolitical tensions continue to escalate worldwide, leaders of the Asia–Pacific Economic Cooperation (APEC) are gathering in South Korea for the 2025 APEC Economic Leaders' Meeting, a pivotal moment as the region navigates deepening global economic uncertainty.

Ahead of the meeting, China Media Group (CMG), together with Yonsei University and YTN, held a panel discussion in Beijing on October 25 under the theme “Dialogue on Global Governance and Asia–Pacific Shared Prosperity.”

Ren Hongbin, chairman of the China Council for the Promotion of International Trade, said countries' interests are increasingly intertwined, requiring stronger shared governance, with cooperation and mutual benefit as essential. He noted China's Global Governance Initiative (GGI) offers Chinese solutions for a fairer global system. Tengku Zafrul Aziz, Malaysia's minister of investment, trade and industry, stressed that rules, trust and inclusiveness underpin growth for all nations. Ruben Oyarzo, member of Chile's Chamber of Deputies, affirmed Chile's commitment to Asia–Pacific development and building mutual trust. Yoon Dong–sup, president of Yonsei University, added that addressing climate change, innovation, aging populations, and economic uncertainty depends on dialogue, cooperation, and collective planning for a sustainable future.

As multilateralism faces unprecedented challenges, China has continued to act, notably through its Global Governance Initiative, one of four major global initiatives it has proposed for the world. Panelists praised this approach and underscored the importance of cooperation, engagement and mutual trust, pointing to China's economic resilience as a stabilizing force for global growth.

All participants agreed that, amid today's fragile global economy, cooperation, trust, transparency and innovation are key to sustaining Asia–Pacific growth. David Perez Des Rosiers of the Canada China Business Council called APEC a vital platform for regional opportunities. Gaston Chee of the Malaysian Chamber of Commerce in China emphasized transparency to counter rising trade barriers, while Chung Suh–Yong of the Seoul International Law Academy urged APEC to build open and inclusive partnerships that balance common interests and differences.

Amid global fragmentation and mistrust, China's message is unmistakable: Dialogue, cooperation and shared prosperity offer a path toward renewal.

https://news.cgtn.com/news/2025–10–27/Dialogue–development–and–shared–prosperity–1HOlRvc1WLu/p.html

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/aef85933–62bf–42f3–a691–f6d01320017d


GLOBENEWSWIRE (Distribution ID 9562691)

SIAD Announces Selection for 3,500 MTPD ASU for Pacifico Mexinol Project

THE WOODLANDS, Texas, Oct. 27, 2025 (GLOBE NEWSWIRE) — SIAD Americas LLC, announced today that SIAD has been selected to provide an air separation unit (ASU) for the Pacifico Mexinol ultra–low carbon Methanol project in Sinaloa, Mexico. The project, led by SIAD Macchine Impianti, will leverage SIAD’s global execution model, with engineering support from its centers in Bergamo, Italy; The Woodlands, Texas; and Hangzhou, China. Equipment will be sourced from the United States, China, and Europe, with fabrication carried out at SIAD facilities in Hangzhou, China and at the new facility in Porto Marghera (Venice), Italy.

The ASU will have a production capacity of approximately 3,500 metric tons per day (MTPD) of high–purity oxygen, making it a critical component for the production of ultra–low carbon methanol. It will supply the large volumes of oxygen required for the project's gasification and carbon capture processes.

“We are proud to partner with Transition Industries and contribute our expertise to what will be one of the world's most sustainable chemical facilities,” said Ed Hotard, Chairman and CEO of SIAD Americas. “Our selection reflects the strength of SIAD’s global engineering team and our commitment to delivering exceptional value to customers.”

Paolo Ferrario, General Manager of SIAD Macchine Impianti, added, “Being chosen for this landmark project is a testament to SIAD's global engineering capabilities and our proven technology in large–scale air separation.”

Once operational in 2029, Pacifico Mexinol is expected to be the largest standalone ultra–low–carbon chemical production facility in the world and one of the world’s largest producers of green hydrogen and green methanol. Transition Industries is jointly developing Pacifico Mexinol with the International Finance Corporation (IFC), a member of the World Bank Group.

Rommel Gallo, Transition Industries CEO, said: “The selection of SIAD for this critical piece of infrastructure ensures that the Pacifico Mexinol project will be equipped with a world–class, highly efficient air separation plant. This partnership is another key step in integrating the best available technology to meet our ambitious sustainability and operational goals.”

The ASU will be designed to the highest standards of efficiency and reliability, supporting the project's net–zero carbon emissions objectives. The strategic sourcing of engineering and equipment from SIAD's global network is expected to optimize the project's execution schedule and cost.

About SIAD Americas LLC and SIAD Macchine Impianti S.p.A.
SIAD Americas LLC, based in The Woodlands, TX, is the Americas operating subsidiary of SIAD Macchine Impianti S.p.A., the engineering subsidiary of the SIAD Group (SIAD S.p.A.). SIAD is a family–owned industrial gases and engineering company operating globally, established in 1927 and headquartered in Bergamo, Italy. With $1.1 billion in annual revenue and 2,278 employees, SIAD is a leading global provider of engineered equipment including air separation units (ASU), nitrogen washing units, small scale natural gas liquefiers (LNG), CO2 capture and liquefaction plants, biogas upgrading systems, combustion systems, and reciprocating compressors for process gases. SIAD has supplied over 500 ASUs, 300 CO2 plants, and more than 5,000 reciprocating compressors to customers worldwide.

About Transition Industries
Transition Industries LLC, based in Houston, Texas, is a developer of world–scale, net–zero carbon emissions methanol and green hydrogen projects in North America to address climate change and promote environmental and social sustainability. For additional information about Pacifico Mexinol or Transition Industries, email [email protected].

Contact: Anica Arena
  SIAD Americas LLC
  346.380.1268
  info@siad–americas.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/13e1d10b–6719–457e–bb1d–abe29a541e37


GLOBENEWSWIRE (Distribution ID 9562660)

Curia Invests $4 Million to Enhance Sterile API Manufacturing

ALBANY, N.Y., Oct. 27, 2025 (GLOBE NEWSWIRE) — Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of a $4 million investment to upgrade its two API aseptic suites in Valladolid, Spain. The investment aligns with the latest EU GMP Annex 1 standards and reinforces Curia’s longstanding commitment to regulatory excellence and product quality. Annex 1 provides general guidance for the design and control of facilities, equipment, systems and procedures used for the manufacture of all sterile products, applying the principles of Quality Risk Management (QRM) to prevent microbial, particulate and endotoxin contamination in the final product.

The enhancements support upgrades to Valladolid’s infrastructure and technology. Curia used innovative tools to take advantage of new possibilities derived from the application of an enhanced process understanding. The bulk of the investment was dedicated to updating the site’s equipment, including the installation of new isolators, along with modernizations to HVAC, pharmaceutical panels, automation, sterilization in place and general utilities. Transitioning to a fully closed system was the primary driver of these upgrades, with the goal of supporting process and product safety and preventing microbiological contamination at every step of production. Additionally, ergonomic improvements for operators were key to increasing operational safety, along with the implementation of additional automatic controls in line with stricter data integrity policies, as described in 21 CFR Part 11.    

“Quality and compliance are integral to how we operate,” said Philip Macnabb, CEO of Curia. “The new Annex 1 requirements align with our proactive approach to quality control. We always strive to offer our customers the highest level of assurance when it comes to compliance and our ability to deliver high–quality sterile APIs at scale. Customers depend on us for reliability, precision and trust. With these improvements at Valladolid, they can feel confident that we will continue to invest ahead of industry trends as we partner with them to bring their products to market.”

The updates at Valladolid followed a company–wide evaluation across Curia’s global network to identify opportunities for improvement related to new Annex 1 requirements. The assessment examined procedures, equipment, utilities, qualifications, and validations to create solutions tailored to each site and to address any areas for optimization.

Curia’s global API aseptic processing manufacturing network has served a broad portfolio of customers worldwide for more than 20 years. This investment positions the company to support increasingly complex manufacturing projects, while strengthening its commitment to delivering life–changing medicines with uncompromising quality and reliability.

About Curia
Curia is a contract research, development and manufacturing organization (CDMO) with over 30 years of experience, an integrated network of 20 global sites and 3,200 employees partnering with biopharmaceutical customers to bring life–changing therapies to market. Our offerings in small molecule, generic APIs, sterile drug product and biologics span discovery through commercialization, with integrated regulatory, analytical and sterile fill–finish capabilities. Our scientific and process experts, along with our regulatory–compliant facilities, provide a best–in–class experience across drug substance and drug product manufacturing. From curiosity to cure, we deliver every step to accelerate your research and improve patients’ lives. Visit us at curiaglobal.com.

Corporate Contact:
Viana Bhagan
Curia
+1 518 512 2111
[email protected]


GLOBENEWSWIRE (Distribution ID 9552034)

Curia Investe US $4 Milhões para Aprimorar a Fabricação de APIs Estéreis

ALBANY, N.Y., Oct. 27, 2025 (GLOBE NEWSWIRE) — Curia Global, Inc. (Curia), uma organização líder global em pesquisa, desenvolvimento e fabricação, anunciou hoje a conclusão de um investimento de US $4 milhões para atualizar suas duas suítes assépticas de API em Valladolid, Espanha. O investimento está alinhado com os mais recentes padrões do Anexo 1 de BPF da UE e confirma o compromisso de longa data da Curia com a excelência regulatória e a qualidade do produto. O Anexo 1 fornece orientações gerais para o projeto e controle de instalações, equipamentos, sistemas e procedimentos utilizados para a fabricação de todos os produtos estéreis, aplicando os princípios de Gerenciamento de Risco da Qualidade (QRM) para prevenir a contaminação microbiana, particulada e de endotoxina no produto final.

Estes aprimoramentos são compatíveis com as atualizações da infraestrutura e tecnologia da Valladolid. A Curia usou ferramentas inovadoras para aproveitar novas possibilidades derivadas da aplicação de uma compreensão aprimorada do processo. A maior parte do investimento foi dedicada à atualização dos equipamentos do local, incluindo a instalação de novos isoladores, juntamente com modernizações de HVAC, painéis farmacêuticos, automação, esterilização no local e utilidades gerais. A transição para um sistema totalmente fechado foi o principal impulsionador dessas atualizações, com o objetivo de apoiar a segurança do processo e do produto e prevenir a contaminação microbiológica em cada etapa da produção. Além disso, os aprimoramentos ergonômicos para os operadores foram fundamentais para aumentar a segurança operacional, juntamente com a implementação de controles automáticos adicionais de acordo com políticas de integridade de dados mais rigorosas, de acordo com 21 CFR Parte 11.    

“A qualidade e a conformidade são essenciais para a nossa operação”, disse Philip Macnabb, CEO da Curia. “Os novos requisitos do Anexo 1 se alinham com nossa abordagem proativa ao controle de qualidade. Sempre nos esforçamos para oferecer aos nossos clientes o mais alto nível de garantia quando se trata de conformidade e da nossa capacidade de fornecer APIs estéreis de alta qualidade em escala. Os clientes dependem de nós para confiabilidade, precisão e confiança. Com essas melhorias em Valladolid tem a confiança de que continuaremos a investir à frente das tendências do setor à medida que nos associamos a eles para levar seus produtos ao mercado.”

As atualizações em Valladolid seguiram uma avaliação de toda a empresa em toda a rede global da Curia para identificar oportunidades de melhoria relacionadas aos novos requisitos do Anexo 1. A avaliação analisou procedimentos, equipamentos, utilidades, qualificações e validações para criar soluções adaptadas a cada local e abordar quaisquer áreas para otimização.

A rede global de fabricação de processamento asséptico de API da Curia atende a um amplo portfólio de clientes em todo o mundo há mais de 20 anos. Esse investimento posiciona a empresa a apoiar projetos de fabricação cada vez mais complexos, ao mesmo tempo em que fortalece seu compromisso de fornecer medicamentos com qualidade e confiabilidade intransigentes que mudam a vida.

Sobre a Curia
A Curia é uma Organização de Desenvolvimento e Fabricação por Contratos (CDMO) com mais de 30 anos de experiência, uma rede integrada de 20 locais em todo o mundo e 3.200 funcionários em parcerias com clientes biofarmacêuticos para lançamento no mercado terapias que mudam a vida. Nossas ofertas de pequenas moléculas, APIs genéricos, produtos de medicamentos estéreis e produtos biológicos resultam em descobertas através da comercialização, com integridade regulatória, de capacidade analítica e processamento final estéril. Nossos especialistas científicos e de processos, juntamente com nossas instalações em conformidade regulatórias, oferecem a melhor experiência em fabricação de medicamentos e produtos farmacêuticos. Da curiosidade à cura, proporcionamos todas as etapas necessárias para acelerar sua pesquisa e melhorar a vida dos pacientes. Visite–nos em curiaglobal.com.

Contato Corporativo:
Viana Bhagan
Curia
+1 (518) 512 2111
[email protected]


GLOBENEWSWIRE (Distribution ID 9562221)

Curia investiert 4 Mio. US-Dollar in die Optimierung der Herstellung steriler Wirkstoffe

ALBANY, New York, Oct. 27, 2025 (GLOBE NEWSWIRE) — Curia Global, Inc. (Curia), ein weltweit führendes Forschungs–, Entwicklungs– und Produktionsunternehmen, gab heute den Abschluss einer 4 Millionen US–Dollar schweren Investition zur Modernisierung seiner beiden aseptischen API–Anlagen in Valladolid, Spanien, bekannt. Die Investition entspricht den neuesten Standards des EU–GMP–Anhangs 1 und unterstreicht das langjährige Engagement von Curia für regulatorische Exzellenz und Produktqualität. Anhang 1 enthält allgemeine Leitlinien für die Gestaltung und Kontrolle von Anlagen, Ausrüstung, Systemen und Verfahren, die für die Herstellung aller sterilen Produkte verwendet werden. Dabei werden die Grundsätze des Qualitätsrisikomanagements (QRM) angewendet, um eine Kontamination des Endprodukts mit Mikroorganismen, Partikeln und Endotoxinen zu verhindern.

Die Verbesserungen unterstützen die Modernisierung der Infrastruktur und Technologie in Valladolid. Curia nutzte innovative Tools, um neue Möglichkeiten zu erschließen, die sich aus einem verbesserten Prozessverständnis ergaben. Der Großteil der Investitionen floss in die Modernisierung der Anlagen am Standort. Dazu gehörten die Installation neuer Isolatoren, die Modernisierung der Klimaanlagen, der pharmazeutischen Schalttafeln, der Automatisierung, der Sterilisation vor Ort sowie der allgemeinen Versorgungsanlagen. Der Hauptgrund für diese Modernisierungen war der Übergang zu einem vollständig geschlossenen System. Damit sollten die Prozess– und Produktsicherheit gewährleistet und mikrobiologische Kontaminationen in jeder Phase der Produktion verhindert werden. Ergonomische Verbesserungen waren darüber hinaus für die Erhöhung der Betriebssicherheit von entscheidender Bedeutung. Ebenso wichtig war die Implementierung zusätzlicher automatischer Kontrollen gemäß den strengeren Richtlinien zur Datenintegrität, wie in 21 CFR Part 11 beschrieben.    

„Qualität und Compliance sind wesentliche Bestandteile unserer Geschäftstätigkeit“, sagte Philip Macnabb, CEO von Curia. „Die neuen Anforderungen in Anhang 1 sind mit unserem proaktiven Ansatz zur Qualitätskontrolle vereinbar. Wir sind stets bestrebt, unseren Kunden ein Höchstmaß an Sicherheit in Bezug auf die Einhaltung von Vorschriften sowie unsere Fähigkeit zur Lieferung hochwertiger, steriler Wirkstoffe in großem Maßstab zu bieten. Unsere Kunden verlassen sich auf unsere Zuverlässigkeit, Präzision und Vertrauenswürdigkeit. Mit diesen Verbesserungen in Valladolid können sie darauf vertrauen, dass wir weiterhin vor den Branchentrends investieren werden, um gemeinsam mit ihnen ihre Produkte auf den Markt zu bringen.

Die Aktualisierungen in Valladolid erfolgten auf Basis einer unternehmensweiten Bewertung des globalen Curia–Netzwerks, mit der Verbesserungsmöglichkeiten im Zusammenhang mit den neuen Anforderungen des Anhangs 1 identifiziert wurden. Die Bewertung umfasste Verfahren, Ausrüstung, Versorgungsanlagen, Qualifikationen und Validierungen, um maßgeschneiderte Lösungen für jeden Standort zu entwickeln und Optimierungsmöglichkeiten zu ermitteln.

Seit mehr als 20 Jahren bedient das globale Netzwerk von Curia für die aseptische Verarbeitung von APIs ein breites Spektrum von Kunden weltweit. Dank dieser Investition ist das Unternehmen nun in der Lage, immer komplexere Fertigungsprojekte zu realisieren und gleichzeitig sein Engagement für die Bereitstellung lebensverändernder Medikamente in kompromissloser Qualität und Zuverlässigkeit zu verstärken.

Über Curia
Curia ist ein Auftragsforschungs–, Entwicklungs– und Produktionsunternehmen (CDMO) mit über 30 Jahren Erfahrung, einem integrierten Netzwerk von 20 Standorten weltweit und 3.200 Mitarbeitern, das mit Kunden aus der Biopharmazie zusammenarbeitet, um lebensverändernde Therapien auf den Markt zu bringen. Unser Angebot an niedermolekularen Wirkstoffen, generischen Wirkstoffen, sterilen Arzneimitteln und Biologika deckt den gesamten Prozess von der Entdeckung bis zur Vermarktung ab. Dazu gehören auch integrierte Kompetenzen in den Bereichen Zulassung, Analytik und sterile Abfüllung. Unsere Wissenschafts– und Prozessexperten sowie unsere Einrichtungen, die den behördlichen Vorschriften entsprechen, bieten erstklassige Kompetenz bei der Herstellung von Arzneimittelwirkstoffen und –produkten. Von der Neugier bis zur Heilung – wir unterstützen Sie bei jedem Schritt, um Ihre Forschung zu beschleunigen und das Leben von Patienten zu verbessern. Besuchen Sie uns unter curiaglobal.com.

Kontakt zum Unternehmen:
Viana Bhagan
Curia
+1 518 512 2111
[email protected]


GLOBENEWSWIRE (Distribution ID 9562221)

Curia investit 4 millions de dollars pour renforcer la fabrication stérile de substances actives (API)

ALBANY, New York, 27 oct. 2025 (GLOBE NEWSWIRE) — Curia Global, Inc. (Curia), l’une des principales organisations de recherche, de développement et de fabrication sous contrat, a annoncé aujourd’hui l’achèvement d’un investissement de 4 millions de dollars destiné à moderniser ses deux unités aseptiques de production de substances actives (API) à Valladolid, en Espagne. Cet investissement s’inscrit dans le cadre des dernières normes de l’annexe 1 des BPF de l’Union européenne (EU GMP Annex 1) et réaffirme l’engagement de longue date de Curia en matière d’excellence réglementaire et de qualité produit. L’annexe 1 fournit des orientations générales concernant la conception et le contrôle des installations, équipements, systèmes et procédures utilisés pour la fabrication de produits stériles. Elle applique les principes de la gestion des risques qualité (QRM) afin de prévenir toute contamination microbienne, particulaire ou endotoxinique des produits finis.

Ces améliorations soutiennent la modernisation des infrastructures et des technologies du site de Valladolid. Curia a eu recours à des outils innovants afin d’exploiter pleinement les opportunités offertes par une meilleure compréhension des procédés. La majeure partie de l’investissement a été consacrée à la modernisation des équipements du site, avec l’installation de nouveaux isolateurs et la mise à niveau des systèmes de ventilation (CVC), des panneaux pharmaceutiques, de l’automatisation, de la stérilisation in situ et des utilités générales. La transition vers un système entièrement fermé a été le principal moteur de ces améliorations, visant à renforcer la sécurité des procédés et des produits et à prévenir toute contamination microbiologique à chaque étape de la production. Par ailleurs, des améliorations ergonomiques pour les opérateurs ont été essentielles pour renforcer la sécurité opérationnelle, accompagnées de la mise en place de contrôles automatiques supplémentaires, conformes aux politiques plus strictes d’intégrité des données, telles que décrites dans le 21 CFR Part 11.

« La qualité et la conformité sont au cœur de notre fonctionnement », a déclaré Philip Macnabb, PDG de Curia. « Les nouvelles exigences de l’annexe 1 s’inscrivent dans notre approche proactive du contrôle qualité. » « Nous nous efforçons en permanence d’offrir à nos clients le plus haut niveau de garantie en matière de conformité, ainsi que notre capacité à fournir des substances actives stériles de haute qualité à grande échelle. » « Nos clients comptent sur nous pour notre fiabilité, notre rigueur et la confiance qu’ils peuvent nous accorder. » « Grâce à ces améliorations sur le site de Valladolid, nos clients peuvent être assurés que nous continuerons à investir en avance sur les tendances du secteur, tout en les accompagnant dans la mise sur le marché de leurs produits. »

Les améliorations apportées au site de Valladolid font suite à une évaluation menée à l’échelle mondiale au sein du réseau de Curia, afin d’identifier les opportunités d’optimisation en lien avec les nouvelles exigences de l’annexe 1. L’évaluation a porté sur les procédures, les équipements, les utilités, les qualifications et les validations, afin de concevoir des solutions adaptées à chaque site et de traiter toutes les opportunités d’optimisation.

Le réseau mondial de fabrication aseptique de substances actives (API) de Curia dessert un large portefeuille de clients à travers le monde depuis plus de 20 ans. Cet investissement permet à l’entreprise de soutenir des projets de fabrication de plus en plus complexes, tout en renforçant son engagement à fournir des médicaments capables de transformer la vie des patients, avec une qualité et une fiabilité sans compromis.

À propos de Curia
Curia est une organisation de recherche, de développement et de fabrication sous contrat (ou CDMO pour Contract Development and Manufacturing Organization) forte de plus de 30 ans d’expérience à son actif. Elle exploite un réseau intégré de plus de 20 sites à travers le monde et emploie quelque 3 200 collaborateurs travaillant en partenariat avec des clients biopharmaceutiques pour mettre sur le marché des traitements qui changent véritablement la vie. Nos offres en matière de petites molécules, d’API génériques et de produits biologiques couvrent le cycle complet de la découverte à la commercialisation, et intègrent des capacités réglementaires, analytiques et de remplissage et finition stériles. Nos experts en sciences et en processus, ainsi que nos installations conformes à la réglementation, offrent une expérience de premier ordre dans la fabrication de substances et de produits pharmaceutiques. De la curiosité au traitement, nous réalisons toutes les étapes permettant d’accélérer vos recherches et d’améliorer la vie des patients. Consultez notre site à l’adresse curiaglobal.com.

Contact de l’entreprise :
Viana Bhagan
Curia
+1 518 512 2111
[email protected]


GLOBENEWSWIRE (Distribution ID 9562221)

Neinor Homes completes €140mn ABB, eyeing further growth opportunities in a buoyant Spanish Residential market

MADRID, Oct. 27, 2025 (GLOBE NEWSWIRE) — Neinor successfully raised €140mn through an accelerated bookbuild offering (ABB) through the issuance of 8,900,190 new shares at €15.73/sh.

Orion, Neinor’s largest shareholder, subscribed €100mn, reinforcing its long–term commitment to the company and confidence on its equity efficient growth strategy.

An additional €40mn was subscribed by existing shareholders who continue to support the company following the €229mn ABB successfully executed in June.

Spain remains one of the safest residential markets globally, being structurally undersupplied, underleveraged and offering compelling long–term growth opportunities in a highly fragmented market.

Over the past 2.5 years Neinor, and its strategic partners, have closed land acquisitions worth more than +€2,700mn to develop c.31,000 housing units targeting opportunistic returns.

With the acquisition of AEDAS fully funded, Neinor expects to use net proceeds to pursue further growth opportunities in Build–to–Sell and the emerging Alternative Living segments.

Borja García–Egotxeaga, CEO of Neinor Homes, commented: “We are very pleased with the outcome of this transaction and the continued support from Orion, which once again demonstrates its confidence in Neinor’s long–term strategy and growth potential, as well as from institutional investors who have reaffirmed their backing. The proceeds will allow us to continue expanding in the most attractive segments of the Spanish market while maintaining a disciplined approach to capital deployment.”

Jordi Argemí, Deputy CEO and CFO, stated: “This capital raise further strengthens Neinor’s balance sheet and enhances our capacity to execute on the pipeline currently under analysis. The participation of our cornerstone shareholder alongside other long–term institutional investors underscores the strong confidence in Neinor’s strategy, execution, and value creation potential. Following its €50mn equity investment in Neinor’s asset management business in 2023, Orion’s participation in this transaction represents a renewed show of commitment to the company and its long–term vision.”

* For the full regulatory announcement please refer to Neinor’s webpage (https://www.neinorhomes.com/en/corporate/investors/market–notifications/other–relevant–information/)


GLOBENEWSWIRE (Distribution ID 1001135256)